APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 2 filers reported holding APTEVO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,000 | +200.0% | 9,142 | +128.2% | 0.00% | – |
| Q3 2019 | $2,000 | – | 4,006 | +2570.7% | 0.00% | – |
| Q2 2019 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 150 | -75.3% | 0.00% | – |
| Q4 2018 | $1,000 | -95.2% | 608 | -85.1% | 0.00% | – |
| Q3 2018 | $21,000 | -87.0% | 4,068 | -87.5% | 0.00% | – |
| Q2 2018 | $162,000 | +5.2% | 32,565 | -30.8% | 0.00% | – |
| Q1 2018 | $154,000 | +32.8% | 47,039 | +72.3% | 0.00% | – |
| Q4 2017 | $116,000 | -27.0% | 27,303 | -60.8% | 0.00% | – |
| Q3 2017 | $159,000 | -35.9% | 69,562 | -41.9% | 0.00% | – |
| Q2 2017 | $248,000 | -49.2% | 119,790 | -49.5% | 0.00% | – |
| Q1 2017 | $488,000 | -46.5% | 237,308 | -36.6% | 0.00% | – |
| Q4 2016 | $912,000 | +37.1% | 374,550 | +44.0% | 0.00% | – |
| Q3 2016 | $665,000 | – | 260,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 974,492 | $2,495,000 | 0.55% |
| Perceptive Advisors | 988,133 | $2,530,000 | 0.16% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 38,860 | $99,000 | 0.07% |
| Laurel Wealth Advisors, Inc. | 42,890 | $110,000 | 0.05% |
| CSS LLC/IL | 353,977 | $906,000 | 0.04% |
| GLG Partners LP | 396,486 | $1,015,000 | 0.03% |
| Capital Impact Advisors, LLC | 12,318 | $32,000 | 0.01% |
| Spark Investment Management LLC | 66,000 | $168,000 | 0.01% |
| Peak Asset Management, LLC | 10,000 | $26,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 99,390 | $254,000 | 0.01% |